Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
EASTERN REGIONAL MEDICAL CENTER, LLC
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Phase 1
Completed
Conditions
Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Precancerous/Nonmalignant Condition
Unspecified Adult Solid Tumor, Protocol Specific
Subscribe
First Posted Date
2004-08-26
Last Posted Date
2013-03-26
Lead Sponsor
Cancer Treatment Centers of America
Target Recruit Count
30
Registration Number
NCT00003406
Locations
🇺🇸
Midwestern Regional Medical Center, Zion, Illinois, United States
Subscribe
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
Phase 2
Completed
Conditions
Breast Cancer
Chronic Myeloproliferative Disorders
Gestational Trophoblastic Tumor
Kidney Cancer
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Neuroblastoma
Ovarian Cancer
Expand All (12)
Subscribe
First Posted Date
2003-05-23
Last Posted Date
2013-03-26
Lead Sponsor
Cancer Treatment Centers of America
Target Recruit Count
40
Registration Number
NCT00003408
Locations
🇺🇸
Midwestern Regional Medical Center, Zion, Illinois, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy